Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Russo

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Seminars in Liver Disease|June 1, 2014
Drug-induced liver injury with autoimmune featuresAndrew S deLemos, David M Foureau, Carl Jacobs, et al.
Radiology|January 31, 2013
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinomaChristoph Wald, Mark W Russo, Julie K Heimbach, et al.
Journal of Clinical Medicine|August 14, 2025
Donor-Recipient Race Mismatch Is Associated with Lower Survival After Liver Transplantation for Primary Sclerosing CholangitisMark W Russo, Will Wheless, Wida S Cherikh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis CMark W Russo, Joseph A Galanko, Steven L Zacks, et al.
Clinical & Experimental Gastroenterology & Hepatology|April 9, 2019
Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis CHossein Sendi, Marjan Mehrab-Mohseni, Mark W Russo, et al.
The American Journal of Gastroenterology|March 18, 2006
The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRITilak U Shah, Richard C Semelka, Ertan Pamuklar, et al.
British Journal of Haematology|August 4, 2017
Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 studyChristian Michel Zwaan, Jerzy Kowalczyk, Claudine Schmitt, et al.
Journal of the American Board of Family Medicine : JABFM|October 18, 2022
Primary Care Evaluation of a Hepatitis C Virus (HCV) Screening Education InterventionThomas Ludden, Lindsay Shade, Jeremy Thomas, et al.
Hepatology Communications|February 12, 2026
A systematic review of post-liver transplantation treatment and outcomes for late T-cell mediated, chronic ductopenic, and antibody-mediated rejectionYianni Protopapadakis, Thomas D Schiano, Helen S Te, et al.
Hepatology (Baltimore, Md.)|September 8, 2020
Modeling the Hepatology Workforce in the United States: A Predicted Critical ShortageMark W Russo, Oren K Fix, Ayman A Koteish, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Seminars in Liver Disease|June 1, 2014
Drug-induced liver injury with autoimmune featuresAndrew S deLemos, David M Foureau, Carl Jacobs, et al.
Radiology|January 31, 2013
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinomaChristoph Wald, Mark W Russo, Julie K Heimbach, et al.
Journal of Clinical Medicine|August 14, 2025
Donor-Recipient Race Mismatch Is Associated with Lower Survival After Liver Transplantation for Primary Sclerosing CholangitisMark W Russo, Will Wheless, Wida S Cherikh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis CMark W Russo, Joseph A Galanko, Steven L Zacks, et al.
Clinical & Experimental Gastroenterology & Hepatology|April 9, 2019
Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis CHossein Sendi, Marjan Mehrab-Mohseni, Mark W Russo, et al.
The American Journal of Gastroenterology|March 18, 2006
The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRITilak U Shah, Richard C Semelka, Ertan Pamuklar, et al.
British Journal of Haematology|August 4, 2017
Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 studyChristian Michel Zwaan, Jerzy Kowalczyk, Claudine Schmitt, et al.
Journal of the American Board of Family Medicine : JABFM|October 18, 2022
Primary Care Evaluation of a Hepatitis C Virus (HCV) Screening Education InterventionThomas Ludden, Lindsay Shade, Jeremy Thomas, et al.
Hepatology Communications|February 12, 2026
A systematic review of post-liver transplantation treatment and outcomes for late T-cell mediated, chronic ductopenic, and antibody-mediated rejectionYianni Protopapadakis, Thomas D Schiano, Helen S Te, et al.
Hepatology (Baltimore, Md.)|September 8, 2020
Modeling the Hepatology Workforce in the United States: A Predicted Critical ShortageMark W Russo, Oren K Fix, Ayman A Koteish, et al.
Pageof 13